Wei Zong

574 total citations
8 papers, 445 citations indexed

About

Wei Zong is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Wei Zong has authored 8 papers receiving a total of 445 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Cancer Research and 2 papers in Oncology. Recurrent topics in Wei Zong's work include MicroRNA in disease regulation (3 papers), Cancer-related Molecular Pathways (2 papers) and Cancer-related molecular mechanisms research (2 papers). Wei Zong is often cited by papers focused on MicroRNA in disease regulation (3 papers), Cancer-related Molecular Pathways (2 papers) and Cancer-related molecular mechanisms research (2 papers). Wei Zong collaborates with scholars based in China, United States and Italy. Wei Zong's co-authors include Karen S. Yee, Craig B. Thompson, Douglas R. Green, Gerry Melino, Marco Ranalli, Francesca Bernassola, Marco Corazzari, Karen H. Vousden, Richard A. Knight and Ping Wang and has published in prestigious journals such as Journal of Biological Chemistry, Biochemical and Biophysical Research Communications and Journal of Investigative Dermatology.

In The Last Decade

Wei Zong

7 papers receiving 441 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wei Zong China	7	328	190	94	58	49	8	445
Karen Rother Germany	14	350 1.1×	208 1.1×	77 0.8×	58 1.0×	29 0.6×	19	500
Sung‐Wei Lee Taiwan	14	283 0.9×	155 0.8×	174 1.9×	39 0.7×	32 0.7×	38	492
Mariam Gachechiladze Czechia	11	255 0.8×	207 1.1×	81 0.9×	67 1.2×	18 0.4×	30	486
Yong‐Jian Deng China	12	237 0.7×	153 0.8×	108 1.1×	53 0.9×	19 0.4×	21	424
Rosa Viñas-Castells Spain	9	417 1.3×	180 0.9×	96 1.0×	67 1.2×	15 0.3×	9	519
Ai Ping Lee-Lim United States	4	213 0.6×	274 1.4×	131 1.4×	50 0.9×	52 1.1×	4	403
Yvonne E. Smith Ireland	9	228 0.7×	185 1.0×	130 1.4×	32 0.6×	22 0.4×	10	430
Byung–Kyu Ryu South Korea	10	374 1.1×	135 0.7×	120 1.3×	59 1.0×	18 0.4×	11	562
Deepika Kassen United Kingdom	5	364 1.1×	298 1.6×	93 1.0×	77 1.3×	18 0.4×	6	557
Saswati Karmakar United States	12	467 1.4×	301 1.6×	165 1.8×	58 1.0×	28 0.6×	20	692

Countries citing papers authored by Wei Zong

Since Specialization

Citations

This map shows the geographic impact of Wei Zong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Zong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Zong more than expected).

Fields of papers citing papers by Wei Zong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei Zong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Zong. The network helps show where Wei Zong may publish in the future.

Co-authorship network of co-authors of Wei Zong

This figure shows the co-authorship network connecting the top 25 collaborators of Wei Zong. A scholar is included among the top collaborators of Wei Zong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei Zong. Wei Zong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Ma, Lin, Meng Xu, Wei Zong, et al.. (2025). HMGB1 downregulates DDX3 to activate the MAPK pathway, promoting the progression of colorectal cancer. Cancer Gene Therapy. 32(12). 1307–1318.

2.

Wang, Ping, Xueyan Guo, Wei Zong, et al.. (2019). PGC‐1α/SNAI1 axis regulates tumor growth and metastasis by targeting miR‐128b in gastric cancer. Journal of Cellular Physiology. 234(10). 17232–17241. 20 indexed citations

3.

Zong, Wei, Yu Chen, Ping Wang, & Lei Dong. (2016). Overexpression of SASH1 Inhibits TGF-β1-Induced EMT in Gastric Cancer Cells. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 24(1). 17–23. 30 indexed citations

4.

Wang, Ping, et al.. (2015). MicroRNA-128b suppresses tumor growth and promotes apoptosis by targeting A2bR in gastric cancer. Biochemical and Biophysical Research Communications. 467(4). 798–804. 21 indexed citations

5.

Zong, Wei, et al.. (2012). The Correlation between the CLEC16A Gene and Genetic Susceptibility to Type 1 Diabetes in Chinese Children. International Journal of Endocrinology. 2012. 1–5. 7 indexed citations

6.

Lin, Fubao, Zhi Pan, Lauren K. Macri, et al.. (2010). Fibronectin Growth Factor-Binding Domains Are Required for Fibroblast Survival. Journal of Investigative Dermatology. 131(1). 84–98. 55 indexed citations

7.

Zong, Wei & Ute M. Moll. (2008). p53 in autophagy control. Cell Cycle. 7(19). 2947–2948. 13 indexed citations

8.

Melino, Gerry, Francesca Bernassola, Marco Ranalli, et al.. (2004). p73 Induces Apoptosis via PUMA Transactivation and Bax Mitochondrial Translocation. Journal of Biological Chemistry. 279(9). 8076–8083. 299 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact